Role of Interleukin-6, Its Receptor and Soluble gp130 in Chronic Lung Disease of Prematurity

Publisher： Karger

E-ISSN： 1661-7819|104|3|161-167

ISSN： 1661-7800

Source： Neonatology, Vol.104, Iss.3, 2013-07, pp. : 161-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis in Lung Development, Injury and Repair: Implications for Chronic Lung Disease of Prematurity

By  

Neonatology, Vol. 91, Iss. 4, 2007-06 ,pp. : 291-297

Karger

Access to resources Recommend Favorite

Administration of inhaled medication via a tracheostomy in infants with chronic lung disease of prematurity

By Subhedar N. V.   Doyle C.   Shaw N. J.  

Pediatric Rehabilitation, Vol. 3, Iss. 2, 1999-04 ,pp. : 41-42

Informa Healthcare

Access to resources Recommend Favorite

Chronic Lung Disease of Prematurity: Long-Term Respiratory Outcome

By  

Neonatology, Vol. 105, Iss. 4, 2014-05 ,pp. : 352-356

Karger

Access to resources Recommend Favorite

Functional and Antigenic Concentrations of Alpha-1-Proteinase Inhibitor after Administration for the Prevention of Chronic Lung Disease of Prematurity

By  

Neonatology, Vol. 76, Iss. 3, 1999-08 ,pp. : 134-143

Karger

Access to resources Recommend Favorite

The Expression of HoxB5 and its Role in Neonatal Rats with Chronic Lung Disease

By Xu Wei   Yang Ni   Pan Li   Fu Jianhua   Xue Xindong  

Fetal and Pediatric Pathology, Vol. 31, Iss. 1, 2012-01 ,pp. : 11-20

Informa Healthcare

Access to resources Recommend Favorite